Literature DB >> 696666

Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus.

R C Haggitt, J Tryzelaar, F H Ellis, H Colcher.   

Abstract

Prolonged reflux esophagitis leads to replacement of the esophageal squamous epithelium by columnar epithelium in some patients. This columnar epithelium resembles gastric or intestinal mucosa and has been implicated as a precursor of esophageal adenocarcinoma. A review of 14 cases of primary esophageal adenocarcinoma disclosed that 12 (86%) arose in a columnar epithelium-lined (Barrett's) esophagus. Ten of the 12 patients had a hiatal hernia or symptoms of reflux esophagitis or both. In ten patients the columnar epithelium adjacent to and remote from the invasive adenocarcinoma showed a spectrum of abnormalities ranging from mild dysplasia to carcinoma in situ. These data support the concept that esophageal adenocarcinoma is one complication of a columnar epithelium-lined esophagus, and suggest that the invasive carcinoma evolves through a sequence of epithelial dysplasia and carcinoma in situ in most cases. Esophageal biopsy and cytology can detect this dysplasia, and should provide an effective means for monitoring patients with Barrett's esophagus for impending malignancy.

Entities:  

Mesh:

Year:  1978        PMID: 696666     DOI: 10.1093/ajcp/70.1.1

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  82 in total

1.  The phenotype of gastric mucosa coexisting with Barrett's oesophagus.

Authors:  M Rugge; V Russo; G Busatto; R M Genta; F Di Mario; F Farinati; D Y Graham
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

2.  Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer?

Authors:  Shyam Menon; Peter Nightingale; Nigel Trudgill
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

3.  Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Owen Korn; Juan Carlos Díaz; Jorge Rojas
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

Review 4.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

Review 5.  Barrett's oesophagus--to screen or not to screen?

Authors:  M Atkinson
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

6.  Pyloric gland adenoma arising in Barrett's esophagus with mucin immunohistochemical and molecular cytogenetic evaluation.

Authors:  Ryoji Kushima; Michael Vieth; Ken-Ichi Mukaisho; Rie Sakai; Hidetoshi Okabe; Takanori Hattori; Horst Neuhaus; Franz Borchard; Manfred Stolte
Journal:  Virchows Arch       Date:  2005-04-19       Impact factor: 4.064

7.  Dysplasia in Barrett's esophagus.

Authors:  H G Schmidt; R H Riddell; B Walther; D B Skinner; J F Riemann
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

8.  Clinical and histologic follow-up after antireflux surgery for Barrett's esophagus.

Authors:  Steven P Bowers; Samer G Mattar; C Daniel Smith; J Patrick Waring; John G Hunter
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

9.  Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults.

Authors:  A Chak; T Lee; M F Kinnard; W Brock; A Faulx; J Willis; G S Cooper; M V Sivak; K A B Goddard
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 10.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.